- You are here: Home
- Resources
- Explore & Learn
- Toxicokinetics & Pharmacokinetics
- Experimental Methods for Identifying Drug-Drug Interactions
Support
-
Cell Services
- Cell Line Authentication
- Cell Surface Marker Validation Service
-
Cell Line Testing and Assays
- Toxicology Assay
- Drug-Resistant Cell Models
- Cell Viability Assays
- Cell Proliferation Assays
- Cell Migration Assays
- Soft Agar Colony Formation Assay Service
- SRB Assay
- Cell Apoptosis Assays
- Cell Cycle Assays
- Cell Angiogenesis Assays
- DNA/RNA Extraction
- Custom Cell & Tissue Lysate Service
- Cellular Phosphorylation Assays
- Stability Testing
- Sterility Testing
- Endotoxin Detection and Removal
- Phagocytosis Assays
- Cell-Based Screening and Profiling Services
- 3D-Based Services
- Custom Cell Services
- Cell-based LNP Evaluation
-
Stem Cell Research
- iPSC Generation
- iPSC Characterization
-
iPSC Differentiation
- Neural Stem Cells Differentiation Service from iPSC
- Astrocyte Differentiation Service from iPSC
- Retinal Pigment Epithelium (RPE) Differentiation Service from iPSC
- Cardiomyocyte Differentiation Service from iPSC
- T Cell, NK Cell Differentiation Service from iPSC
- Hepatocyte Differentiation Service from iPSC
- Beta Cell Differentiation Service from iPSC
- Brain Organoid Differentiation Service from iPSC
- Cardiac Organoid Differentiation Service from iPSC
- Kidney Organoid Differentiation Service from iPSC
- GABAnergic Neuron Differentiation Service from iPSC
- Undifferentiated iPSC Detection
- iPSC Gene Editing
- iPSC Expanding Service
- MSC Services
- Stem Cell Assay Development and Screening
- Cell Immortalization
-
ISH/FISH Services
- In Situ Hybridization (ISH) & RNAscope Service
- Fluorescent In Situ Hybridization
- FISH Probe Design, Synthesis and Testing Service
-
FISH Applications
- Multicolor FISH (M-FISH) Analysis
- Chromosome Analysis of ES and iPS Cells
- RNA FISH in Plant Service
- Mouse Model and PDX Analysis (FISH)
- Cell Transplantation Analysis (FISH)
- In Situ Detection of CAR-T Cells & Oncolytic Viruses
- CAR-T/CAR-NK Target Assessment Service (ISH)
- ImmunoFISH Analysis (FISH+IHC)
- Splice Variant Analysis (FISH)
- Telomere Length Analysis (Q-FISH)
- Telomere Length Analysis (qPCR assay)
- FISH Analysis of Microorganisms
- Neoplasms FISH Analysis
- CARD-FISH for Environmental Microorganisms (FISH)
- FISH Quality Control Services
- QuantiGene Plex Assay
- Circulating Tumor Cell (CTC) FISH
- mtRNA Analysis (FISH)
- In Situ Detection of Chemokines/Cytokines
- In Situ Detection of Virus
- Transgene Mapping (FISH)
- Transgene Mapping (Locus Amplification & Sequencing)
- Stable Cell Line Genetic Stability Testing
- Genetic Stability Testing (Locus Amplification & Sequencing + ddPCR)
- Clonality Analysis Service (FISH)
- Karyotyping (G-banded) Service
- Animal Chromosome Analysis (G-banded) Service
- AAV Biodistribution Analysis (RNA ISH)
- Molecular Karyotyping (aCGH)
- Droplet Digital PCR (ddPCR) Service
- Digital ISH Image Quantification and Statistical Analysis
- SCE (Sister Chromatid Exchange) Analysis
- Biosample Services
- Histology Services
- Exosome Research Services
- In Vitro DMPK Services
-
In Vivo DMPK Services
- Pharmacokinetic and Toxicokinetic
- PK/PD Biomarker Analysis
- Bioavailability and Bioequivalence
- Bioanalytical Package
- Metabolite Profiling and Identification
- In Vivo Toxicity Study
- Mass Balance, Excretion and Expired Air Collection
- Administration Routes and Biofluid Sampling
- Quantitative Tissue Distribution
- Target Tissue Exposure
- In Vivo Blood-Brain-Barrier Assay
- Drug Toxicity Services
Experimental Methods for Identifying Drug-Drug Interactions
Metabolism-mediated drug-drug interactions (DDI) refer to the interference of simultaneously administered drugs with each other's ADME (absorption, distribution, metabolism, and elimination) process by inducing or inhibiting the activities of drug-metabolizing enzymes and/or drug transporters. These interactions can significantly affect drug efficacy and safety, and thus it is imperative to identify and comprehend them during the drug development phase.
Types of Drug-Drug Interactions
- Pharmacokinetic interactions. These interactions involve changes in the absorption, distribution, metabolism, or excretion of drugs. For example, one drug may inhibit the activity of enzymes responsible for the metabolism of another drug, leading to increased systemic exposure and potential toxicity.
- Pharmacodynamic interactions. Pharmacodynamic interactions occur when drugs with similar or opposing pharmacological effects are co-administered, resulting in synergistic or antagonistic effects. For instance, the combination of two drugs with sedative properties may lead to enhanced sedation.
- Chemical interactions between drugs. These interactions occur when drugs react chemically in vitro (e.g. when mixed for use). For example, two drugs may produce new compounds when used together that affect the stability and efficacy of the drug.
In Vivo Experimental Methods for the Identification of DDIs
- Enzyme inhibition and induction assays. Predict drug metabolic interactions in vivo by analyzing the inhibition or induction of metabolic enzymes (e.g., cytochrome P450 enzymes) by the drug.
- Transporter protein assays. To assess the effects of drugs on transporter proteins (e.g., P-glycoprotein) and predict possible drug interactions during absorption, distribution, and excretion in vivo.
- Protein binding assays: predict drug distribution interactions in vivo by determining the extent of drug binding to plasma proteins.
In Vitro Experimental Methods for the Identification of DDIs
- Animal experiments on drug interactions. Two or more drugs are given simultaneously in an animal model, and changes in pharmacokinetic and pharmacodynamic parameters of the drugs in the animals are observed, to hypothesize the possible drug interactions.
- Clinical drug interaction experiment. In human clinical trials, drug interactions in the body are evaluated by administering two or more drugs and monitoring parameters such as blood concentrations, pharmacodynamic indices, and adverse reactions to the drugs.
- Observational study. Collecting data on patients' drug use, efficacy, and adverse reactions during actual clinical treatment and analyzing the risk of drug interactions through epidemiological methods.
Creative Bioarray Relevant Recommendations
Creative Bioarray provides high-quality drug-drug interaction services, including identification of drug-metabolizing enzymes, CYP and UGT inhibition assays, and inhibition studies towards less common metabolizing enzymes, such as MAO, FMO, NAT, AOX, and CES.
Services Types | Details |
Enzyme Inhibition Assays |
|
Transporter Inhibition and Substrate Assays |
|
For research use only. Not for any other purpose.